Influence of the Type of Membrane and Heparin on Serum Lipid Parameters during a Dialysis Session: A Pilot Study

Background/Aim: The type of heparin and membrane used might influence the lipids in patients on hemodialysis (HD). However, there are limited and debatable data concerning the lipid changes during an HD session. The aim of our study was to examine the changes in serum lipid parameters during the HD session in relation to the heparin and dialysis membrane used. Methods: Ten patients on HD 3 times/week participated in the study. The study was performed in three phases (A, B, C), each of 1 week’s duration. The types of membranes used were Hemophan (phase A), ethylene vinyl alcohol (phase B) and polyacrylonitrile (phase C), respectively, in a random order. During the midweek session of each phase we used classic heparin, while during the session at the end of the week low molecular weight heparin was administered. Serum total cholesterol, triglycerides, HDL cholesterol, Lp(a), albumin and total proteins were measured before and 5 min after the HD and hourly during the HD session. Results: In all phases, we found a progressive increase in all lipid parameters during the HD session, except Lp(a). This increase, however, was possibly due to hemoconcentration. Conclusions: This pilot study showed that (1) the type of heparin and membrane used does not seem to affect the serum lipid profile during a single HD procedure, and (2) the changes observed in serum lipid parameters are mainly due to hemoconcentration.

[1]  B. Agroyannis,et al.  Alterations of plasma lipoprotein (a) concentration. Do they arise from the haemodialysis procedure? , 1996, Nephrology, Dialysis and Transplantation.

[2]  F. Modena,et al.  Prevention of hepatitis C virus infection in a haemodialysis centre. , 1996, Nephrology, Dialysis and Transplantation.

[3]  B. Gordon,et al.  Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  P J Blankestijn,et al.  High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. , 1995, Journal of the American Society of Nephrology : JASN.

[5]  P. Nilsson-ehle,et al.  Different types of heparin in haemodialysis: long-term effects on post-heparin lipases. , 1994, Scandinavian journal of clinical and laboratory investigation.

[6]  W. G. Wood,et al.  Acute changes in concentrations of apolipoproteins A-I, B, C-II and lipoprotein(a) in serum covering the period from directly before to 48 hours after chronic haemodialysis. , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[7]  P. Demacker,et al.  The role of modification of lipoproteins and of the immune system in early atherogenesis. , 1993, The Netherlands journal of medicine.

[8]  O. Samuelsson,et al.  Lipoprotein metabolism and renal failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  M. Seishima,et al.  Transient changes of serum lipoprotein(a) as an acute phase protein. , 1989, Atherosclerosis.

[10]  J. Bergström,et al.  NO CHANGE IN CORRECTED β2-MICROGLOBULIN CONCENTRATION AFTER CUPROPHANE HAEMODIALYSIS , 1987, The Lancet.

[11]  C. Comty,et al.  Protein metabolism in renal failure. , 1973, Urology.

[12]  N. Levin,et al.  Improvement of plasma lipoprotein profiles during high-flux dialysis. , 1993, Journal of the American Society of Nephrology : JASN.